Hims & Hers partners with Novo Nordisk to sell Wegovy on its platform
April 29 (Reuters) - Danish drugmaker Novo Nordisk NOVOb.CO has partnered with Hims & Hers Health's HIMS.N to sell its popular weight loss drug through a bundled offering on the telehealth company's platform, the two companies said on Tuesday.
Customers will get access to the offerings of all dose strengths of Wegovy and a membership at a price starting at $599 per month, Hims said.
The offering is available this week on the Hims & Hers platform, it added.
The companies are building a longer-term roadmap of bundled offerings that will have very unique value and pricing to consumers that hopefully we're able to share in the coming quarters, Hims CEO Andrew Dudum said.
Earlier this month, Hims said it plans to sell Eli Lilly's LLY.N Zepbound on its platform.
While Novo's Wegovy and Lilly's rival drug, Zepbound, were in short supply, several telehealth companies were allowed to sell cheaper copies of the treatments. The branded drugs have since been removed from the U.S. Food and Drug Administration's shortage list, potentially curtailing bulk compounding.
The company will continue to offer personalized compounded versions of semaglutide on its platform, Dudum added.
Semaglutide is the active ingredient in Novo's Wegovy.
Related Articles
Netflix After the Warner Deal: What Investors Should Know
TradingKey - For quite some time now, Netflix (NFLX) has been regarded as the premier subscription-based streaming service in the world, with a well-established history of growth through creative use of pricing power, developing hit programming, and relying very little on outside sources for licensi
Warsh’s Fed Era Signals a Death Knell for QE, Jolting the $30 Trillion Treasury Market
With Warsh’s nomination, his past proposals for governing the Federal Reserve are being brought to the forefront. A central issue is the formulation of a new "1951 Accord" to restructure the relationship between the Fed and the Treasury. Analysts suggest such a move could impact the $30 trillion Tre
Amazon Stock Predictions for 2026 to 2030: Will They Exceed Expectations and Achieve Major Long-Term Goals?
TradingKey - As we head into 2026, many investors are questioning where Amazon (AMZN) fits into the technology world.
A Crash After a Surge: Why Silver Lost 40% in a Week?
TradingKey - Spot silver (XAGUSD) prices continue to decline. Silver plunged 20% on Thursday, breaking below $71 per ounce, with the sell-off intensifying on Friday as prices fell further below $64. Compared to the all-time high set on January 29, silver prices have retraced more than 40%, wiping out nearly all gains accumulated over the previous month.
